Hari Pujar

Hari Pujar serves as Chief Operating Officer at Tessera Therapeutics since October 2020, while concurrently holding a board position at Ring Therapeutics and functioning as an Operating Partner at Flagship Pioneering. With advisory roles at Stony Brook University, New Jersey Innovation Institute, and Jefferson Institute for Bioprocessing, Hari Pujar brings considerable experience in biotechnology and pharmaceuticals. Previous roles include Chief Technology Officer at Spark Therapeutics, Inc. and Head of Technical Development and Manufacturing at Moderna Therapeutics. Pujar's extensive background at Merck & Co., Inc. encompasses leadership positions in global vaccine strategy and external biopharmaceutical R&D. Academic credentials include an MBA from The Wharton School and a PhD in Chemical Engineering from the University of Delaware.